Skip to main content
. Author manuscript; available in PMC: 2020 Dec 8.
Published in final edited form as: Anticancer Res. 2020 Jun;40(6):3147–3153. doi: 10.21873/anticanres.14296

Table II.

Top differentially expressed miRNAs in two independent sample sets.

First set Second set
miRNA Fold change q-value miRNA Fold change q-value
hsa-miR-548am-5p 4.77 <0.05 hsa-miR-5586–5p 1.67 <0.05
hsa-miR-4699–3p 4.45 <0.05 hsa-miR-202–5p 1.63 <0.05
hsa-miR-4498 4.33 <0.05 hsa-miR-20a-3p 1.40 <0.05
hsa-miR-7161–3p 4.17 <0.05 hsa-miR-649 1.34 <0.05
hsa-miR-6805–5p 3.63 <0.05 hsa-miR-6777–5p 1.26 <0.05
hsa-miR-4507 3.21 <0.05 hsa-miR-1307–5p 1.23 <0.05
hsa-miR-1973 2.92 <0.05 hsa-miR-6887–5p 1.21 <0.05
hsa-miR-103b 2.64 <0.05 hsa-miR-4321 1.21 <0.05
hsa-miR-99a-3p 2.18 <0.05 hsa-miR-890 1.2 <0.05
hsa-miR-7113–3p 2.1 <0.05 hsa-miR-4699–5p 1.18 <0.05
hsa-miR-4436b-3p 1.73 <0.05 hsa-miR-1324 1.18 <0.05
hsa-miR-4260 1.48 <0.05 hsa-miR-922 1.15 <0.05